INS and metabolic disease: Nasal insulin administration stimulates hypothalamic insulin signaling to suppress hepatic glucose production and enhance insulin sensitivity in lean individuals, while having little effect in the obese, indicating hypothalamic insulin resistance to be the etiology of metabolic disorders.